Submit Phase I/Phase II clinical trial data: CDSCO Panel Tells Mankind on Dydrogesterone Injection 5mg/ml Dr. Divya Colin9 Sept 2024 5:00 PM ISTNew Delhi: Responding to the proposal presented by Mankind for the grant of permission to manufacture and market Dydrogesterone Injection 5mg/ml, the...
No risk of birth defects: Use of Progesterone safer in first trimester than Dydrogesterone, claims DEBC Study Medha Baranwal6 Aug 2024 8:00 PM ISTChina: A recent study, known as the Maternal Drug Exposure Birth Cohort (DEBC), has been conducted in China to examine the effects of maternal drug...
Oral dydrogesterone could not prevent miscarriages in women with threatened miscarriage: Study Lalhmangaihkimi22 May 2024 7:15 AM ISTBangkok: A recent study in Thai pregnant women concluded that oral dydrogesterone 20 mg per day could not prevent miscarriages in women with...
Abbott gets CDSCO Panel Nod To study FDC Dydrogesterone plus Estradiol Dr. Divya Colin14 March 2024 6:00 PM ISTNew Delhi: The drug major Abbott has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Mankind Pharma Introduces Dydroboon 30mg Sustained Release Tablets for Treatment of Endometriosis MD Brand Connect5 March 2024 11:46 AM ISTOpening doors to convenience for patients suffering from endometriosis, Mankind Pharma, a leading Indian pharmaceutical company, has announced the...
Dydrogesterone exposure during early pregnancy associated with the reporting of birth defects, says Global PV Study Dr. Kamal Kant Kohli27 Nov 2023 9:45 AM ISTDydrogesterone use during early pregnancy was associated with increased reporting of birth defects, including congenital heart defects and...
Synokem Pharma Gets CDSCO Panel Nod to Study Dydrogesterone SR Tablet Dr. Divya Colin12 Oct 2023 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Abbott Gets CDSCO Panel Nod to Study Dydrogesterone Modified Release Tablets Dr. Divya Colin10 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has given its nod to drug major...
Zydus Healthcare gets CDSCO Panel Nod To Manufacture, Market Dydrogesterone Extended Release Tablet Dr. Divya Colin5 Oct 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO Panel Tells Abbott India to revise phase IV CT protocol of Dydrogesterone plus Estradiol Tablets Dr. Divya Colin24 Sept 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined the drug major Abbott...
CDSCO panel rejects Mankind Pharma's Proposal to Study Dydrogesterone Tablets Kit Dr. Divya Colin21 Sept 2023 6:00 PM ISTNew Delhi: Citing the proposed drug is not approved anywhere in the world, the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct Bioequivalence Study: CDSCO panel tells Abbott India on Dydrogesterone MR Tablets Dr. Divya Colin6 Aug 2023 6:00 PM ISTNew Delhi: Responding to the proposal for manufacturing and marketing synthetic progesterone, Dydrogesterone Modified-release (MR) Tablets presented...
